Nakaya, A., Fujita, S., Satake, A., Nakanishi, T., Azuma, Y., Tsubokura, Y., . . . Nomura, S. (2017). Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents. Case Rep Oncol.
Chicago Style CitationNakaya, Aya, et al. "Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis With Conventional Agents." Case Rep Oncol 2017.
Cita MLANakaya, Aya, et al. "Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis With Conventional Agents." Case Rep Oncol 2017.
Atenció: Aquestes cites poden no estar 100% correctes.